20 Mar 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/eckert--ziegler-and-atomvie-global-radiopharma-sign-a-global-agreement-for-lutetium-177-supply-302406500.html
13 Mar 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/blue-earth-therapeutics-reports-key-results-from-lutetium-177lu-rhpsma-10-1-injection-phase-1-clinical-trial-302400601.html
24 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/09/24/2952191/0/en/Curium-Announces-the-Official-Opening-its-New-Netherlands-Facility-for-the-Production-of-Lutetium-177-a-Game-Changer-Therapy-Isotope-for-Cancer-Patients-Worldwide.html
09 Jul 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/en/news-release/2024/07/09/2910486/0/en/Curium-Submits-New-Drug-Application-for-Lutetium-Lu-177-Dotatate-Injection.html
05 Jun 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/06/05/2893669/0/en/Curium-Adds-the-Institut-Laue-Langevin-Reactor-to-Global-Irradiation-Portfolio-to-Ensure-Continuous-Supply-of-Lutetium-177-to-Benefit-More-Than-100-000-Cancer-Patients-Over-the-Nex.html
04 Jun 2024
// Fraiser Kansteiner FIERCE PHARMA
https://www.fiercepharma.com/pharma/bms-and-rayzebio-halt-radiotherapy-trial-enrollment-after-isotope-runs-scarce